Chickasaw Capital Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Chickasaw Capital Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-12,750	Closed	-$22K	–	108
2015 Q2	$22K	Hold	12,750	–	–	﹤0.01%	103
2015 Q1	$18K	Hold	12,750	–	–	﹤0.01%	103
2014 Q4	$19K	Hold	12,750	–	–	﹤0.01%	107
2014 Q3	$26K	Hold	12,750	–	–	﹤0.01%	104
2014 Q2	$39K	Buy	+12,750	New	+$39K	﹤0.01%	103

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Chickasaw Capital Management's RXII Position: Q3 2015 in Review

Chickasaw Capital Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 12,750 shares — an estimated $22K sold.

Chickasaw Capital Management first reported a position in RXII in Q2 2014 and held it in 5 quarters. The position peaked at $39K in Q2 2014. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

Chickasaw Capital Management reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
Chickasaw Capital Management sold 12,750 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $22K.
Chickasaw Capital Management first reported a position in GALENA BIOPHARMA INC COM in Q2 2014 and held it in 5 quarters.
Chickasaw Capital Management's GALENA BIOPHARMA INC COM position peaked at $39K in Q2 2014.
78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Chickasaw Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.